Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Aug 31, 2025 | (Q2)May 31, 2025 | (Q1)Feb 28, 2025 | (FY)Nov 30, 2024 | (Q4)Nov 30, 2024 | (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 25.53%1.32M | -22.91%561.26K | -4.05%803.28K | 26.68%2.39M | -171.63%-230.12K | 324.35%1.06M | 38.64%728.03K | 5.77%837.19K | -27.79%1.89M | -43.95%321.25K |
| Operating revenue | 25.53%1.32M | -22.91%561.26K | -4.05%803.28K | 26.68%2.39M | -171.63%-230.12K | 324.35%1.06M | 38.64%728.03K | 5.77%837.19K | -27.79%1.89M | -43.95%321.25K |
| Cost of revenue | -16.58%218.74K | -18.99%219.9K | -10.06%283.48K | 90.71%1.11M | 32.06%260.39K | -10.95%262.23K | 238.89%271.44K | 10.43%315.2K | -74.52%581.65K | -84.59%197.18K |
| Gross profit | 39.46%1.11M | -25.24%341.36K | -0.42%519.8K | -1.85%1.28M | -495.34%-490.51K | 1,828.85%792.78K | -36.63%456.6K | 3.14%521.98K | 294.82%1.31M | 117.56%124.07K |
| Operating expense | -2,348.98%-9M | -278.45%-2.46M | -32.40%122.64K | -30.30%780.42K | 137.53%843.64K | -145.84%-367.3K | -130.52%-649.51K | -53.74%181.42K | -4.55%1.12M | 23.71%-2.25M |
| Selling and administrative expenses | 52.05%226.56K | 10.99%161.45K | -39.82%88.83K | -33.92%645.16K | 3.53%203.08K | -20.53%149.01K | -38.64%145.46K | -58.50%147.61K | 1.21%976.4K | -29.93%196.15K |
| -Selling and marketing expense | 4.03%22.91K | -34.23%37K | -55.28%30.84K | -43.17%191.2K | 3.54%43.96K | -68.40%22.02K | -51.42%56.26K | -36.45%68.96K | -23.92%336.44K | -70.16%42.46K |
| -General and administrative expense | 60.37%203.65K | 39.51%124.45K | -26.27%57.99K | -29.06%453.96K | 3.53%159.12K | 7.78%126.99K | -26.43%89.21K | -68.18%78.65K | 22.49%639.95K | 11.68%153.69K |
| Depreciation amortization depletion | -0.00%33.82K | 0.00%33.82K | 0.00%33.82K | -5.62%135.27K | 0.00%33.82K | -7.36%33.82K | -7.36%33.82K | -7.36%33.82K | -1.84%143.32K | -7.36%33.82K |
| -Depreciation and amortization | -0.00%33.82K | 0.00%33.82K | 0.00%33.82K | -5.62%135.27K | 0.00%33.82K | -7.36%33.82K | -7.36%33.82K | -7.36%33.82K | -1.84%143.32K | -7.36%33.82K |
| Other operating expenses | -1,582.43%-9.26M | -220.15%-2.65M | ---- | ---- | ---- | -195.31%-550.13K | -144.69%-828.79K | ---- | ---- | ---- |
| Operating profit | 770.69%10.1M | 153.09%2.8M | 16.62%397.16K | 170.02%500.43K | -156.25%-1.33M | 236.96%1.16M | 178.58%1.11M | 199.05%340.56K | 122.00%185.33K | 5.90%2.37M |
| Net non-operating interest income (expenses) | 44.06%-5.01K | 38.56%-6.04K | 34.10%-7.04K | -184.88%-37.49K | 30.40%-8.01K | -9,525.81%-8.95K | -2,537.00%-9.84K | -806.53%-10.69K | -18.18%-13.16K | -367.33%-11.52K |
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | ---- | -99.85%1 | ---- | ---- | ---- |
| Non-operating interest expense | -44.06%5.01K | -38.56%6.04K | -34.10%7.04K | 184.88%37.49K | -30.40%8.01K | 9,525.81%8.95K | 2,537.00%9.84K | 806.53%10.69K | 18.18%13.16K | 367.33%11.52K |
| Other net income (expenses) | 855.42%122.28K | -205.56%-517.79K | -19.45%-908.7K | 241.77%5.43M | 236.73%4.92M | 110.80%12.8K | 1,092.68%490.5K | -570.58%-760.75K | 60.39%-3.83M | 62.11%-3.6M |
| Gain on sale of security | ---- | ---- | -22.90%-949K | 334.24%5.21M | ---- | ---- | ---- | -1,576.96%-772.17K | 76.40%-2.23M | ---- |
| Special income (charges) | --0 | -192.94%-440.39K | ---- | 105.15%65.53K | 67.92%-408.3K | --0 | --473.82K | ---- | -3,190.46%-1.27M | -34,186.50%-1.27M |
| -Less:Impairment of capital assets | ---- | ---- | ---- | 39.38%95.69K | ---- | ---- | ---- | ---- | 1,749.57%68.66K | ---- |
| -Less:Other special charges | ---- | 109.60%10.5K | ---- | ---109.38K | --0 | ---- | ---109.38K | ---- | ---- | ---- |
| -Less:Write off | --0 | --429.89K | ---- | -74.04%312.61K | --312.61K | --0 | --0 | ---- | 7,742.88%1.2M | ---- |
| -Gain on sale of business | --0 | --0 | ---- | --364.45K | --0 | --0 | --364.45K | ---- | --0 | --0 |
| Other non-operating income (expenses) | 625.50%129.68K | -234.26%-68.25K | -16.00%51.18K | 703.21%250.14K | 420.28%120.5K | --17.88K | 1,422.55%50.84K | --60.93K | 73.07%-41.47K | -292.94%-37.62K |
| Income before tax | 777.89%10.22M | 43.41%2.28M | -20.36%-518.59K | 261.08%5.9M | 389.20%3.58M | 220.53%1.16M | 208.88%1.59M | -57,813.71%-430.88K | 65.24%-3.66M | 82.96%-1.24M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 777.89%10.22M | 43.41%2.28M | -20.36%-518.59K | 261.08%5.9M | 389.20%3.58M | 220.53%1.16M | 208.88%1.59M | -57,813.71%-430.88K | 65.06%-3.66M | 82.83%-1.24M |
| Net income continuous operations | 777.89%10.22M | 43.41%2.28M | -20.36%-518.59K | 261.08%5.9M | 389.20%3.58M | 220.53%1.16M | 208.88%1.59M | -57,813.71%-430.88K | 65.06%-3.66M | 82.83%-1.24M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 777.89%10.22M | 43.41%2.28M | -20.36%-518.59K | 261.08%5.9M | 389.20%3.58M | 220.53%1.16M | 208.88%1.59M | -76,296.81%-430.88K | 65.06%-3.66M | 82.83%-1.24M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 777.89%10.22M | 43.41%2.28M | -20.36%-518.59K | 261.08%5.9M | 389.20%3.58M | 220.53%1.16M | 208.88%1.59M | -76,296.81%-430.88K | 65.06%-3.66M | 82.83%-1.24M |
| Diluted earnings per share | 440.00%0.81 | 0.00%0.04 | 0.00%-0.05 | 212.50%0.45 | 389.20%0.282 | 250.00%0.15 | 126.67%0.04 | -47,976.92%-0.05 | 81.40%-0.4 | 93.04%-0.0975 |
| Basic earnings per share | 1,000.00%0.55 | 0.00%0.01 | 0.00%-0.05 | 175.00%0.3 | 274.35%0.17 | 150.00%0.05 | 106.67%0.01 | -47,976.92%-0.05 | 81.40%-0.4 | 93.04%-0.0975 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.